3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow
Clinical trial NCT01183897 · COMPLETED
Trial details
- NCT number
- NCT01183897
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-12
- Primary completion
- 2018-09-25
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.